Scarica l'app Stockscreener
47.69
1.21%
0.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Harrow Inc Borsa (HROW) Ultime notizie
Can Harrow Inc. expand into new markets2025 Market Trends & Weekly Top Gainers Alerts - mfd.ru
Precision Trading with Harrow Health Inc. 8.625% Senior Notes Due 2026 (HROWL) Risk Zones - Stock Traders Daily
Loss Report: What are the future prospects of Harrow IncQuarterly Growth Report & Fast Gain Stock Tips - baoquankhu1.vn
Will Harrow Inc. stock attract more institutional investorsWeekly Trade Report & Weekly High Return Stock Forecasts - mfd.ru
Harrow, Inc. (HROW) Stock Analysis: A 48% Upside in the Promising Ophthalmic Pharmaceuticals Sector - DirectorsTalk Interviews
Is Harrow’s (HROW) Reaffirmed 2025 Guidance Quietly Redefining Its Ophthalmic Growth Strategy? - simplywall.st
Harrow Refocuses After ImprimisRx Exit As New CCO Takes Charge - Sahm
A Look At Harrow’s (HROW) Valuation As 2025 Guidance Is Reaffirmed And Regulatory Issues Clear - Yahoo Finance
New York State Common Retirement Fund Raises Stock Position in Harrow, Inc. $HROW - MarketBeat
B.Riley reiterates Buy rating on Harrow Health stock amid VEVYE growth - Investing.com
Harrow (NASDAQ:HROW) Downgraded by Zacks Research to "Hold" - MarketBeat
Growth Recap: Should I hold or sell Harrow Inc now2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - baoquankhu1.vn
Harrow Reaffirms FY2025 Revenue Growth Range Of 35% To 40%; Expands Sales Force - Nasdaq
Harrow Stock (+9.7%): Commercial Expansion Ignites Institutional Buying - Trefis
Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength? - Nasdaq
Rival quits California market; OSRX steps in to keep eye meds flowing - stocktitan.net
How Harrow Health Inc. (HROW) Affects Rotational Strategy Timing - Stock Traders Daily
Harrow on track to double sales force, expand product reach By Investing.com - Investing.com Nigeria
OSRX Continues Support in California Market After Competitor Exit - Intellectia AI
Harrow (NASDAQ:HROW) Shares Gap UpShould You Buy? - MarketBeat
Harrow on track to double sales force, expand product reach - Investing.com
(HROW) Harrow Expects 2025 Revenue Range $270M$280M, vs. FactSet Est of $273.4M - marketscreener.com
Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth - marketscreener.com
Is Harrow Inc. attractive for institutional investors2025 Winners & Losers & Verified Momentum Stock Alerts - Mfd.ru
Harrow Becomes Oversold (HROW) - Nasdaq
Can Harrow Inc. be recession proofJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru
Risk Report: Is PMTV stock showing strong momentum2025 Price Targets & Low Volatility Stock Recommendations - baoquankhu1.vn
109,421 Shares in Harrow, Inc. $HROW Acquired by Blackhawk Capital Partners LLC - MarketBeat
Harrow, Inc. (NASDAQ:HROW) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 4.4%Time to Sell? - MarketBeat
Market Trends: Can Harrow Inc expand into new marketsJuly 2025 Drop Watch & AI Enhanced Execution Alerts - baoquankhu1.vn
Pharma News: Can Harrow Inc. be recession proofTrade Risk Assessment & Weekly High Return Stock Forecasts - baoquankhu1.vn
Investment Recap: Can OptimizeRx Corporation weather a recessionQuarterly Trade Review & Weekly Setup with ROI Potential - baoquankhu1.vn
Breakeven Is Near for Harrow, Inc. (NASDAQ:HROW) - Yahoo Finance
Assessing Harrow (HROW) Valuation After Its Shift To An Integrated U.S. Eye Care Pharma Platform - Sahm
LJI Wealth Management LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN
Harrow, Inc. (NASDAQ:HROW) Could Be Less Than A Year Away From Profitability - 富途资讯
Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - sharewise.com
Harrow, Inc. (HROW): A Bull Case Theory - Finviz
Zacks Research Upgrades Harrow (NASDAQ:HROW) to "Strong-Buy" - MarketBeat
Gap Down: Can Harrow Inc maintain sales growthBull Run & Safe Capital Allocation Plans - baoquankhu1.vn
Harrow: Flirting With Missing 2025 Revised Guidance (NASDAQ:HROW) - Seeking Alpha
Value Recap: Will Harrow Inc benefit from geopolitical trendsWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn
Responsive Playbooks and the HROW Inflection - Stock Traders Daily
1.19%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):